Invictus MD announces $40,000,000 Bought Deal Private Placement of Convertible Debentures and notice of intention to exercise option on Acreage Pharms

Posted on Categories: Investor Relations

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC, April 20, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announced today that it has engaged Canaccord Genuity Corp. and Eventus Capital Corp., as co-lead underwriters and joint-bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters“), pursuant to which the Underwriters have agreed to purchase, on a bought deal private placement basis, subject to adjustment pursuant to the Underwriters’ Option (as hereinafter defined), $40 million aggregate principal amount of convertible debentures (the “Convertible Debentures“) at a price of $1,000 per Convertible Debenture (the “Offering“).

Read more “Invictus MD announces $40,000,000 Bought Deal Private Placement of Convertible Debentures and notice of intention to exercise option on Acreage Pharms”

Canopy Growth Corporation Enters Into An Agreement with Invictus MD’s AB Laboratories For Cannabis Sales

Posted on Categories: Investor Relations

VANCOUVER, BC, April 19, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), will provide their unique products in Canopy Growth Corporation’s (TSX:WEED) (“Canopy Growth”) curated CraftGrow line on Tweed Main Street’s online store, that brings high quality cannabis grown by a diverse set of producers. People want variety, they want different choices, and Tweed Main Street is an opportunity in the legal market where patients can see what is available through the convenience of an online store.

Read more “Canopy Growth Corporation Enters Into An Agreement with Invictus MD’s AB Laboratories For Cannabis Sales”

Invictus MD’s Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector

Posted on Categories: Investor Relations

VANCOUVER, BC, April 13, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.787 million in revenue for the 9 months ending March 31, 2017, with a gross margin of $907,864, representing a 50.8% gross margin compared to the same period in the prior year gross margin of $642,773, and a 35.9% margin.

Read more “Invictus MD’s Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector”

Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis

Posted on Categories: Investor Relations

Vancouver, BC, April 11, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. (“Acreage Pharms”) which Invictus MD has the option to now acquire 100 percent and expect to exercise in short order, begins their new cultivation cycle, having received their license to cultivate under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), they are firmly committed to patient safety and the quality of their cannabis.

Read more “Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis”